GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug ...
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently undervalued according to InvestingPro Fair Value metrics, has reached a ...
MP Materials Corp. (NYSE:MP), the largest rare earth producer outside of China and currently valued at $3.48 billion, is positioning itself as a key player in the global rare earth elements (REE) ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...
Airbnb, Inc. (NASDAQ:ABNB), the leading online marketplace for short-term lodging and experiences with a market capitalization of $79.28 billion, finds itself at a crossroads as it navigates a complex ...
GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...
Sky Force, set to release on 24 January 2025, promises to be an adrenaline-fueled action-adventure that blends patriotism with spectacular aerial combat. Directed by Sandeep Kewlani and produced ...
Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...
Credit: Bloomberg via Getty Images. GSK has announced a definitive agreement to acquire IDRx, a US-based biotechnology company specialising in treatments for gastrointestinal cancers, for up to ...
Key stocks in focus include General Insurance Corp, ONGC, SpiceJet, GSK Pharma, and Cipla due to various developments. Notable updates include the government's stake sale in General Insurance Corp and ...